Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity

Abstract Targeting personalized tumor neoantigens is a promising strategy in immuno-oncotherapy, tumor heterogeneity requires that adaptive immunity be effectively induced against a broad spectrum of neoantigens for a significant anti-tumor effect. We developed several non-integrative lentiviral vec...

Full description

Saved in:
Bibliographic Details
Main Authors: Benjamin Vesin, Ingrid Fert, Amandine Noirat, Pierre Authié, Sylvain Ciret, Catherine Blanc, Yakov Vitrenko, Pierre Charneau, Laleh Majlessi, François Anna
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01199-6
Tags: Add Tag
No Tags, Be the first to tag this record!